EDGAR Filing Documents for 0001571049-16-020107

Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:

SEC Accession No. 0001571049-16-020107

Filing Date

2016-11-23

Accepted

2016-11-23 09:13:03

Documents

Effectiveness Date

2016-11-23

Document Format Files

Seq	Description	Document	Type	Size
1	POST-EFFECTIVE AMENDMENT NO.1	t1602921_posex.htm	POS EX	40056
2	EXHIBIT 5.1	t1602921_ex5-1.htm	EX-5.1	15313
3	GRAPHIC	t1602907_ex5-1p1.jpg	GRAPHIC	6860
	Complete submission text file	0001571049-16-020107.txt		66039

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-214230 | Film No.: 162014967
SIC: 2834 Pharmaceutical Preparations